This management's discussion and analysis of financial condition and results of
operations ("MD&A"), contains forward-looking statements that involve risks and
uncertainties. Please see "Important Information Regarding Forward-Looking
Statements" for a discussion of the uncertainties, risks, and assumptions that
may cause our actual results to differ materially from those discussed in the
forward-looking statements. This discussion should be read in conjunction with
our unaudited condensed consolidated financial statements and related notes
thereto and the other disclosures contained elsewhere in this Quarterly Report
on Form 10-Q, and the audited consolidated financial statements and related
notes thereto for the fiscal year ended December 31, 2020, which were included
in our Form 10-K, filed with the SEC on March 29, 2021.
The results of operations for the periods reflected herein are not necessarily
indicative of results that may be expected for future periods.
Overview
The year 2020 marked the first full year that Star Equity, known prior to
January 1, 2021 as Digirad Corporation, operated as a multi-industry holding
company. With the acquisition of ATRM in September 2019, we added construction
businesses to what had historically been a healthcare company and thereby
transformed the Company into a diversified holding company with operating
businesses in two important industry sectors of the economy, healthcare and
construction.

Our Healthcare division, which is operated as Digirad Health, provides products
and services in the area of nuclear medical imaging with a focus on cardiac
health. Digirad Health operates across the U.S. The healthcare business involves
two reporting segments, Diagnostic Services, which offers imaging services to
healthcare providers using a fleet of our proprietary solid-state gamma cameras
and Diagnostic Imaging, which manufactures, distributes and maintains our
proprietary solid-state gamma cameras.

Our Construction division is a single reporting segment but is made up of three
operating business, KBS, EdgeBuilder and Glenbrook. KBS is based in Maine and
manufactures modular buildings for installation throughout the New England
market. EdgeBuilder and Glenbrook, referred to together as "EBGL" internally and
based in the Minneapolis-Saint Paul area, together manufacture structural wall
panels and other engineered wood-based products as well as distribute building
materials to professional builder customers in the Upper Midwest.

Currently, our Investments division is an internally-focused unit that is directly supervised by Star Equity management and is responsible for the management of our real estate and investments, which currently includes our three manufacturing facilities in Maine that are leased to KBS.

Strategy

Star Equity
We believe our diversified, multi-industry holding company structure will allow
Star Equity management to focus on capital allocation, strategic leadership,
mergers and acquisitions, capital markets transactions, investor relations,
management of our real estate and investments, and other public company
activities. Our structural will free up our operating Chief Executive Officers
to manage their respective businesses, look for organic and bolt-on growth
opportunities and improve operations, with fewer distractions and administrative
burdens.

We continue to explore strategic alternatives to improve the market position and
profitability of our product offerings in the marketplace, generate additional
liquidity, and enhance our valuation. We may pursue our goals through organic
growth or through strategic transactions. Some of these strategic transactions
have included, and could continue to include, selective acquisitions of business
segments or entire businesses, divestitures of assets or divisions, or a
restructuring of our company.

We seek to grow our business by, among other things:
•Organic growth from our core businesses. We believe that we operate in markets
and geographies that will allow us to continue to grow our core businesses,
allowing us to benefit from our scale and strengths. We plan to focus our
efforts on markets in which we already have a presence in order to take
advantage of personnel, infrastructure, and brand recognition we have in these
areas.
                                       39
--------------------------------------------------------------------------------


•Introduction of new services. In the Healthcare division, we plan to continue
to focus on healthcare solutions related businesses that deliver necessary
assets, services and logistics directly to the customer site. We believe that
over time we can either purchase or develop new and complementary businesses and
take advantage of our customer loyalty and distribution channels. In the
Construction division, we will consider opportunities to augment our service
offering to better serve our customer base. We have done this in the New England
market by adding a structural wall panel line. Other areas might include
logistics, installation on site, and manufacturing of sub-components or
enhancements that create even more complete modules, such as full HVAC
installation.
•Acquisition of complementary businesses. We plan to continue to look at
complementary businesses that meet our internally developed financially
disciplined approach for acquisitions to grow our company. We believe there are
many potential small targets that can be acquired over time and integrated into
our platform. We will also look at larger, more transformational acquisitions
(public or private) if we believe the appropriate mix of value, risk and return
is present for our shareholders. The timing of these potential acquisitions will
always depend on market conditions, available capital, and the value for each
transaction. In general, we want to be "value" buyers, and will not pursue any
transaction unless we believe the post-transaction potential value is high for
shareholders.
We continue to explore strategic alternatives to improve the market position and
profitability of our product offerings in the marketplace, generate additional
liquidity, and enhance our valuation. We may pursue our goals through organic
growth and through strategic alternatives. Some of these alternatives have
included, and could continue to include, selective acquisitions of business
segments or entire businesses, divestitures of assets or divisions, or a
restructuring of our company.
Current Market Conditions
The year 2020 proved to be a challenging year for the vast majority of
businesses across many sectors of the economy. With the COVID-19 vaccine rollout
now well underway, we are hopeful that we will soon make our way back to
pre-COVID levels of business activity. We believe the uncertainty surrounding
the pandemic will continue to decrease as we progress through 2021. On the
healthcare side, we expect to see imaging volume recover as the pandemic is
brought under control. In construction, we expect that continued recovery in
employment and a strong housing market will underpin the growth we are seeing.
The target market for our healthcare products and services is comprised of
cardiologists, internal medicine physicians, family practice physicians,
hospitals, IDNs, and federal institutions in the United States that perform or
could perform a diagnostic imaging procedure, have a need for cardiac event
monitoring, or have interest in purchasing a diagnostic imaging products. Our
diagnostic services businesses currently operate in approximately 25 states. The
overriding challenge during 2020 was the drop in imaging volume due to the
COVID-19 pandemic. During the three months ended March 31, 2021, while we
provide critical and important imaging services focused in the cardiac area, the
risks of exposure led to reduced patient volumes as these tests were deferred or
canceled in hopes that the pandemic would abate.
The target market for our construction division includes residential home
builders, general contractors, owners or developers of commercial buildings, and
individual retail customers. While we witnessed a number of municipalities,
especially in the Boston area, shutdown construction sites during the early wave
of infections and even shutdown our own plant in South Paris, Maine for six
weeks in April and May of 2020, housing demand and demand for building materials
have increased as the COVID-19 pandemic has led to "nesting" at home, which were
positive factors in the second half of 2020 and have continued through the first
quarter of 2021. The challenge has been less on the demand side and more on the
supply chain, as wood-based commodities prices, lumber and OSB, have increased
rapidly coming out of the first wave of the pandemic in the Spring of 2020 and
supply has not kept up with demand. We have seen some supply chain disruption
and tightness during the second half of 2020 and that has continued into 2021 as
lead times have extended out, but we are still able to operate at normal levels
of production. We believe that the high price environment that we are currently
experiencing will lead to additional supply coming on line later this year.
                                       40
--------------------------------------------------------------------------------


Trends and Drivers
The market for diagnostic services and products is highly competitive. Our
business, which is focused primarily on the private practice and hospital
sectors, continues to face uncertainty in the demand for diagnostic services and
imaging equipment, which we believe is due in part to the impact of the Deficit
Reduction Act on the reimbursement environment and the 2010 Healthcare Reform
laws, COVID-19 pandemic impact, as well as general uncertainty in overall
healthcare and legislative changes in healthcare, such as the Affordable Care
Act. These challenges have impacted, and will likely continue to impact, our
operations. We believe that the principal competitive factors in our market
include budget availability for our capital equipment, qualifications for
reimbursement, pricing, ease-of-use, reliability, and mobility. We have
addressed, and will continue to address, these market pressures by modifying our
Diagnostic Services business models, and by assisting our healthcare customers
in complying with new regulations and requirements.
In our construction division, we continue to see a greater adoption of offsite
or prefab construction in single-family and multi-family residential building
projects, our target market. Our modular units and structural wall panels offer
builders a number of benefits over traditional onsite or "stick built"
construction. These include shorter time to market, higher quality, reduced
waste, readily available labor and potential cost savings, among others. 3D BIM
software modeling and developments in engineered wood products offers greater
design flexibility for higher-end applications. The need for more affordable
housing solutions also presents a great opportunity for the continued emergence
of factory built housing.
COVID-19 Pandemic
During the three months ended March 31, 2021, we experienced a $0.4 million
decrease in Healthcare division revenue which was offset by a $3.6 million
increase, in Construction revenue, as compared to the same period of the prior
year. With the COVID-19 vaccine rollout now well underway, we are hopeful that
we will gradually make our way back to pre-COVID levels of business activity. We
believe the uncertainty surrounding the pandemic will continue to decrease as we
progress through 2021. On the healthcare side, we expect to see imaging volume
recover as the pandemic is brought under control. In construction, we expect
that continued recovery in employment and a strong housing market will underpin
the growth we are seeing.
Discontinued Operations
The DMS Sale Transaction was completed on March 31, 2021, for $18.75 million in
cash, subject to certain adjustments, including a working capital adjustment.
The divestiture of DMS Health, which operated our Mobile Healthcare segment, met
the definition of a strategic shift that has a significant effect on our
operations and financial results; therefore, the results of operations for the
Mobile Healthcare segment have been presented as discontinued operations in
accordance with ASC 205-20, Presentation of Financial Statements-Discontinued
Operations for all periods presented. Additionally, Mobile Healthcare's assets
and liabilities as of December 31, 2020 are separately presented as held for
sale on the unaudited consolidated balance sheet. Unless otherwise noted,
discussion within these notes to the unaudited consolidated financial statements
relates to continuing operations.
Business Segments
As of March 31, 2021, our business is organized into four reportable segments:
•Diagnostic Services
•Diagnostic Imaging
•Construction
•Investments
Diagnostic Services
Through this segment, we offer a convenient and economically efficient imaging
and monitoring services program as an alternative to purchasing equipment or
outsourcing the procedures to another physician or imaging center. For
physicians who wish to perform nuclear imaging, echocardiography, vascular or
general ultrasound tests, we provide imaging systems, qualified personnel,
radiopharmaceuticals, licensing services, and the logistics required to perform
imaging in their own offices, and thereby the ability to bill Medicare,
Medicaid, or one of the third-party healthcare insurers directly for those
services, which are primarily cardiac in nature. We provide imaging services
primarily to cardiologists, internal medicine physicians, and family practice
doctors who typically enter into annual contracts for a set number of days
ranging from once per month to five times per week.
                                       41
--------------------------------------------------------------------------------


Diagnostic Imaging
Through this segment, we sell our internally developed solid-state gamma
cameras, imaging systems and camera maintenance contracts. Our imaging systems
include nuclear cardiac imaging systems, as well as general purpose nuclear
imaging systems. We sell our imaging systems to physician offices and hospitals
primarily in the United States, although we have sold a small number of imaging
systems internationally. Our imaging systems are sold in both portable and fixed
configurations, provide enhanced operability and improved patient comfort, fit
easily into floor spaces as small as seven feet by eight feet, and facilitate
the delivery of nuclear medicine procedures in a physician's office, an
outpatient hospital setting, or within multiple departments of a hospital (e.g.,
emergency and operating rooms). Our Diagnostic Imaging segment revenues derive
primarily from selling solid-state gamma cameras and post-warranty camera
maintenance contracts.
Construction
Through this segment, by way of our wholly-owned subsidiaries KBS, Glenbrook and
EdgeBuilder, we service residential and commercial construction projects by
manufacturing modular housing units, structural wall panels, permanent wood
foundation systems, other engineered wood products, and supply general
contractors with building materials. KBS is a Maine-based manufacturer that
started business in 2001 as a manufacturer of modular homes. KBS offers products
for both multi-family and single-family residential buildings with a focus on
customization to suit the project requirements and provide engineering and
design expertise. Glenbrook is a supplier of lumber, windows, doors, cabinets,
drywall, roofing, decking and other building materials to professional builders
and conducts its operations in Oakdale, Minnesota. EdgeBuilder is a manufacturer
of structural wall panels, permanent wood foundation systems and other
engineered wood products and conducts its operations in Prescott, Wisconsin.
Investments

Through this segment, we hold real estate assets that we have acquired and will
potentially manage other future investments of Star Equity. In April 2019, the
Company funded the initial purchase of three manufacturing facilities in Maine
that manufacture modular buildings and leased those three properties back to
KBS. The initial funding of the assets acquisition was primarily through the
revolver loan under our SNB Credit Facility. Since that time, we have secured a
new facility from Gerber to finance these properties.
Healthcare Services and Products
Diagnostic imaging depictions of the internal anatomy or physiology are
generated primarily through non-invasive means. Diagnostic imaging facilitates
the early diagnosis of diseases and disorders, often minimizing the scope, cost,
and amount of care required and reducing the need for more invasive procedures.
Currently, the major types of non-invasive diagnostic imaging technologies
available are: ultrasound and nuclear imaging. The most widely used imaging
acquisition technology utilizing gamma cameras is single photon emission
computed tomography, or SPECT. All our current internally-developed cardiac
gamma cameras employ SPECT technology.
Diagnostic imaging is the standard of care in diagnosis of diseases and
disorders. We offer, through our businesses, the majority of these diagnostic
imaging modalities. All of the diagnostic imaging modalities that we offer (both
from provision of services and product sales) have been consistently utilized in
clinical applications for many years, and are stable in their use and need. By
offering a wide array of these modalities, we believe that we have strategically
diversified our operations in possible changing trends of utilization of one
diagnostic imaging modality from another.
Construction Services and Products
In the construction business, KBS markets its modular homes products through a
direct sales organization and through inside sales, outside sales, a network of
independent dealers, builders, and contractors in the New England states
(Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, and Vermont).
KBS's direct sales organization is responsible for all commercial building
projects, and works with developers, architects, owners, and general contractors
to establish the scope of work, terms of payment, and general requirements for
each project. KBS's sales people also work with independent dealers, builders,
and contractors to accurately configure and place orders for residential homes
for their end customers. KBS's network of independent dealers and contractors do
not work with it exclusively, although many have KBS model homes on display at
their retail centers. KBS does not assign exclusive territories to its
independent dealers and contractors, but they tend to sell in areas of New
England where they will not be competing against another KBS dealer or
contractor. KBS's backlog and pipeline, along with its market initiatives to
build more workforce housing, are expected to position KBS for continued growth.
                                       42
--------------------------------------------------------------------------------

EBGL markets its engineered structural wall panels and permanent wood foundation
systems through direct sales people and a network of builders, contractors and
developers in and around Minneapolis and St. Paul areas. EBGL's direct sales
organization is responsible for both residential and commercial projects and it
works with general contractors, developers and builders to provide bids and
quotes for specific projects. Our marketing efforts include participation in
industry trade shows, production of product literature, and sales support tools.
These efforts are designed to generate sales leads for our independent builders
and dealers, and direct salespeople.
Critical Accounting Policies and Estimates
In preparing our financial statements, we make estimates, assumptions and
judgments that can have a significant impact on our revenue and net income or
loss, as well as on the value of certain assets and liabilities on our balance
sheet. We believe that the estimates, assumptions, and judgments involved in the
accounting policies described in Management's Discussion and Analysis of
Financial Condition and Results of Operations in Item 7 of our Annual Report on
Form 10-K for the fiscal year ended December 31, 2020 have the greatest
potential impact on our financial statements, so we consider them to be our
critical accounting policies and estimates.
Results of Operations
Comparison of the Three Months Ended March 31, 2021 and 2020
The following table summarizes our results for the three months ended March 31,
2021 and 2020 (in thousands):
                                                                                        Three Months Ended March 31,
                                                               Percent of                                 Percent of                   Change from Prior Year
                                            2021                 Revenues               2020                Revenues               Dollars               Percent
Total revenues                          $   22,354                    100.0  %       $ 19,190                    100.0  %       $     3,164                  16.5  %
Total cost of revenues                      19,277                     86.2  %         15,947                     83.1  %             3,330                  20.9  %
Gross profit                                 3,077                     13.8  %          3,243                     16.9  %              (166)                 (5.1) %
Total operating expenses                     4,646                     20.8  %          5,439                     28.3  %              (793)                (14.6) %
Loss from operations                        (1,569)                    (7.0) %         (2,196)                   (11.4) %               627                 (28.6) %
Total other expense                            983                      4.4  %           (145)                    (0.8) %             1,128                (777.9) %
Loss before income taxes                      (586)                    (2.6) %         (2,341)                   (12.2) %             1,755                 (75.0) %
Income tax expense                              (2)                       -  %            (27)                    (0.1) %                25                 (92.6) %
Net loss from continuing
operations                              $     (588)                    (2.6) %       $ (2,368)                   (12.3) %       $     1,780                 (75.2) %


Revenues
Healthcare

Healthcare revenue by segments is summarized as follows (in thousands):


                                             Three Months Ended March 31,
                                     2021              2020        Change      % Change
Diagnostic Services           $    10,239           $ 10,814      $ (575)        (5.3) %

Diagnostic Imaging                  3,068              2,861         207          7.2  %
Total Healthcare Revenue      $    13,307           $ 13,675      $ (368)        (2.7) %



Although Q1 2021 revenues for the Diagnostic Services decreased slightly from Q1
2020, this division has largely recovered and is now performing near
pre-pandemic levels. Most doctor offices have reopened and hospitals are now
performing non-emergency procedures. As state-by-state vaccination levels
increase, we expect to see our operations fully return to normal levels later
this year.
The increase in Diagnostic Imaging is due to higher number of cameras sold
compared to the prior year quarter.
                                       43
--------------------------------------------------------------------------------

Construction

Construction revenue is summarized as follows (in thousands):


                                          Three Months Ended March 31,
                                  2021             2020        Change       % Change
Construction               $    9,047            $ 5,484      $ 3,563         65.0  %
Construction Revenue       $    9,047            $ 5,484      $ 3,563         65.0  %



The increase in revenue for the Construction division was predominately due to
higher production levels at KBS, with $2.7 million in revenue recognized on a
large commercial project.

Investments

Investments revenue is summarized as follows (in thousands):


                                           Three Months Ended March 31,
                                     2021                2020      Change      % Change
Investments                $      -                     $ 31      $  (31)      (100.0) %

Investments Revenue        $      -                     $ 31      $  (31)      (100.0) %


The decrease in investments revenue was due to the wind down of investment
vehicles from LSVM.
Gross Profit
Healthcare Gross Profit
Healthcare gross profit and gross margin by segments is summarized as follows
(in thousands):
                                                    Three Months Ended March 31,
                                             2021                        2020        % Change
Diagnostic Services gross profit       $      1,608                   $ 2,005         (19.8) %
Diagnostic Services gross margin               15.7   %                  

18.5 %



Diagnostic Imaging gross profit        $        990                   $   869          13.9  %
Diagnostic Imaging gross margin                32.3   %                  30.4  %

Total healthcare gross profit          $      2,598                   $ 2,874          (9.6) %
Total healthcare gross margin                  19.5   %                  21.0  %


The decrease in Diagnostic Services gross margin percentage was mainly due to
the COVID-19 pandemic impact and the associated public health measures in place,
which directly reduced scanning revenue. While management proactively applied
measures to contain costs during the pandemic, there were fixed costs which
resulted in the decrease in gross margin.
The increase in Diagnostic Imaging gross margin percentage was mainly due to
higher camera revenue recognized in the three months ended March 31, 2021
compared to the prior year same period.

Construction Gross Profit
Construction gross profit and margin is summarized as follows (in thousands):
                                                Three Months Ended March 31,
                                       2021                            2020       % Change
Construction gross profit        $        544                        $ 403          35.0  %
Construction gross margin                 6.0    %                     7.3  %

The increase in Construction gross profit was predominately due to higher production levels at KBS, with $2.7 million in revenue recognized on a large commercial project. The decrease in gross margin percentage is due to the negative effect of higher raw material prices.


                                       44
--------------------------------------------------------------------------------


Investments Gross Loss
Investments gross loss is summarized as follows (in thousands):
                                             Three Months Ended March 31,
                                            2021                    2020       % Change

Investments gross loss        $          (65)                      $ (34)          91  %


The Investments gross loss relates to depreciation expense associated with the
three manufacturing facilities acquired in April 2019 and investment vehicles
through LSVM. The decrease was due the reduced activities in investment vehicles
from LSVM.
Operating Expenses
Operating expenses are summarized as follows (in thousands):
                                                             Three Months Ended March 31,                                     Percent of Revenues
                                                                                           Change
                                            2021               2020            Dollars             Percent                 2021                  2020
Selling, general and
administrative                          $    5,055          $ 4,863          $    192                    3.9  %               22.6  %              25.3 

%


Amortization of intangible assets              438              576              (138)                 (24.0) %                2.0  %               3.0

%


Gain on sale of MD Office
Solutions                                     (847)               -              (847)                (100.0) %               (3.8) %                 -

%


Total operating expenses                $    4,646          $ 5,439          $   (793)                 (14.6) %               20.8  %              28.3 

%




The $0.2 million increase in sales, general and administrative expenses was
primarily due to a $0.3 million increase in the Construction business as a
result of increased commissions and headcount, offset by $0.1 million reduced
travel expense in Healthcare division.
The $0.1 million decrease in amortization of intangible assets and the $0.8
million gain was due to the sale of MD Office Solutions.
Total Other Income (Expense)
Total other income (expense) is summarized as follows (in thousands):
                                            Three Months Ended March 31,
                                                  2021                     2020
Other income, net                   $          1,255                     $  160
Interest expense, net                           (272)                      (305)

Total other income (expense)        $            983                     $ (145)


Other income, net for three months ended March 31, 2021 is predominantly
comprised of $1.3 million PPP loan forgiveness from KBS and EBGL.
Interest expense, net, for the three months ended March 31, 2021 and 2020 are
predominantly comprised of interest costs and the related amortization of
deferred issuance costs on our debt, respectively.
Income Tax Expense
For the three months ended March 31, 2021, we recorded an income tax expense
from continuing operations of $2 thousand. See Note 10, Income Taxes, within the
notes to our unaudited consolidated financial statements for further information
related to the Company's income taxes.
Income from Discontinued Operations
See Note 2, Discontinued Operations of the unaudited condensed consolidated
financial statements for information regarding discontinued operations.

                                       45
--------------------------------------------------------------------------------


Liquidity and Capital Resources
Overview
We used cash of $2.2 million for operations during the three months ended
March 31, 2021. Cash flow used in operations primarily consist of our net loss
(adjusted for depreciation, amortization, and other non-cash items), and the net
effect of changes in working capital. Cash flow provided by investing activities
was used primarily for investment in capital equipment required to maintain and
grow our business, as well as acquisitions and dispositions. Cash flow from
financing activities primarily consisted of our net proceeds from borrowings on
various revolving facilities and the receipt of cash from the conversion of cash
warrants converted into common stock, offset by the repayments of long-term
borrowings.
Our principal sources of liquidity include our existing cash and cash
equivalents, cash generated from operations, and funds available under various
credit facilities and proceeds from sale of DMS Health. As of March 31, 2021, we
had $13.3 million of cash, cash equivalents and restricted cash and $4.5 million
available under our Sterling revolving line of credit.
We require capital, principally for capital expenditures, acquisition activity,
dividend payments and to finance accounts receivable and inventory. Our working
capital requirements vary from period to period depending on inventory
requirements, the timing of deliveries, and the payment cycles of our customers.
Our capital expenditures consist primarily of medical imaging and diagnostic
devices utilized in the delivery of our services, as well as vehicles and
information technology hardware and software.
Regarding our debt, we had approximately $12.5 million in short term debt due to
our borrowings which is classified as short term as disclosed in Note 8. Debt.
The $5.0 million SNB credit facility primarily supports our healthcare business
and actually matures in 2024, but GAAP rules require that the outstanding
balance be classified as short-term debt, due to the automatic sweep feature
embedded in the traditional lockbox arrangement along with a subjective
acceleration clause in the SNB Loan and Security Agreement. In practice, we have
the ability to immediately borrow back these daily sweeps to fund our working
capital. As of March 31, 2021, we were in compliance with all borrowing
arrangements related to our Healthcare division. As of March 31, 2021, we had
$4.5 million of borrowing capacity to fund the operations of these divisions.
As of March 31, 2021, we have $4.6 millionoutstanding on our Construction
revolvers with Gerber and were in compliance with all borrowing covenants for
Gerber, however, we were in breach of our covenants as of December 31, 2020 and
may be in breach at our next measurement period at June 30, 2021. While Gerber
has historically provided us with waivers, there is no assurance that we will be
able to receive waivers for covenant violations in the future, or that we will
meet compliance with covenants in the future. Related party notes of
$2.3 million was paid off on April 1, 2021 using proceeds from the DMS Sale
Transaction. In addition, as of March 31, 2021, we had cash and cash equivalents
of $13.3 million.
Management believes that the Company has the liquidity and operations to
continue to support the business through the next 12 months from the issuance of
this Quarterly Report. Our ability to continue as a going concern is dependent
on its ability to execute its plans.
Common Stock Equity Offering
On May 28, 2020, we closed a public offering (the "Offering") of 2,225,000
shares of our common stock, and 2,225,000 warrants (the "Warrants") to purchase
up to 1,112,500 additional shares of our common stock. The Offering price was
$2.24 per share of common stock and $0.01 per accompanying Warrant (for a
combined Offering price of $2.25), initially raising $5.0 million in gross
proceeds before underwriter discounts and offering-related expenses. The
underwriting agreement (the "Underwriting Agreement") we entered into with Maxim
Group LLC ("Maxim"), as representative of the underwriters, for the Offering
contained customary representations, warranties, and agreements by the Company,
customary conditions to closing, indemnification obligations of the Company and
Maxim and certain other obligations.
Pursuant to the terms of the Underwriting Agreement, we granted to Maxim an
option for a period of 45 days (the "Over-Allotment Option") to purchase up to
225,000 additional shares of our common stock and 225,000 Warrants to purchase
up to an additional 112,500 shares of our common stock. Effective as of the
closing of the Offering, Maxim exercised the Over-Allotment Option for the
purchase of 225,000 Warrants for a price of $0.01 per Warrant. On June 10, 2020,
Maxim exercised the Over-Allotment Option for the purchase of 225,000 shares of
our common stock for a price of $2.24 per share, before underwriting discounts.
The closing of the sale of the over-allotment shares brought the total number of
shares of common stock we sold in the Offering to 2,450,000 shares, and total
gross proceeds to approximately $5.5 million. In addition, the Company received
$0.5 million from investors in the Offering throughout the balance of March 31,
2021 due to the exercise of a portion of the Warrants sold in the Offering,
bringing the total gross proceeds from equity issuance to $6.5 million.

                                       46
--------------------------------------------------------------------------------


The net proceeds to the Company from the Offering and Warrant exercises in 2020
were approximately $5.2 million (inclusive of the exercise of the over-allotment
option), after deducting underwriter fees and offering-related expenses
estimated at $0.8 million. We used a significant portion of the net proceeds
from the Offering to fund working capital needs at our construction businesses,
particularly related to modular housing projects which we produced at KBS
Builders, Inc. ("KBS") for the Boston-area projects. The remainder of the net
proceeds is being used for working capital and for other general corporate
purposes. We have broad discretion in determining how the proceeds of the
Offering is used, and our discretion is not limited by the aforementioned
possible uses.

As of March 31, 2021, 0.9 million warrants were exercised and 1.5 million warrants remained outstanding at an exercise price of $2.25. Cash Flows The following table shows cash flow information for the three months ended March 31, 2021 and 2020 (in thousands):

Three Months Ended March 31,


                                                                           2021              2020
Net cash (used in) provided by operating activities                    $  (2,232)         $    623
Net cash provided by (used in) investing activities                    $  18,315          $   (135)
Net cash (used in) provided by financing activities                    $  

(6,180) $ (957)




Operating Activities
The increase in cash used compared to the prior year period was primarily due to
increased investment in working capital to fund the revenue growth in the
Construction division.
Investing Activities
The increase in investing activities cash flow compared to the prior year period
was primarily attributable to $18.75 million proceeds received from DMS Health
disposition.
Financing Activities
The decrease in cash flows from financing activities is primarily due to a
$7.9 million pay down of the SNB Credit Facility using the proceeds from the
sale of the DMS Health business.
Sterling Credit Facility
On March 29, 2019, the Company entered into a Loan and Security Agreement (the
"SNB Loan Agreement") by and among certain subsidiaries of the Company, as
borrowers (collectively, the "SNB Borrowers"); the Company, as guarantor; and
Sterling as lender.
The SNB Loan Agreement is a five-year credit facility maturing in March 2024,
with a maximum credit amount of $20.0 million for revolving loans (the "SNB
Credit Facility"). Under the SNB Credit Facility, the SNB Borrowers can request
the issuance of letters of credit in an aggregate amount not to exceed $0.5
million at any one time outstanding. The borrowings under the SNB Loan Agreement
were classified as short-term obligations under GAAP as the agreement contained
a subjective acceleration clause and required a lockbox arrangement whereby all
receipts within the lockbox are swept daily to reduce borrowings outstanding. As
of March 31, 2021, the Company had $0.2 million of letters of credit outstanding
and had additional borrowing capacity of $4.5 million.
At the Borrowers' option, the SNB Credit Facility will bear interest at either
(i) a Floating LIBOR Rate, as defined in the Loan Agreement, plus a margin of
2.50% per annum; or (ii) a Fixed LIBOR Rate, as defined in the Loan Agreement,
plus a margin of 2.25% per annum. As our largest single debt outstanding, our
floating rate on this facility at March 31, 2021 was 2.61%.
                                       47
--------------------------------------------------------------------------------


The SNB Loan Agreement includes certain representations, warranties of SNB
Borrowers, as well as events of default and certain affirmative and negative
covenants by the SNB Borrowers that are customary for loan agreements of this
type. These covenants include restrictions on borrowings, investments and
dispositions by SNB Borrowers, as well as limitations on the SNB Borrowers'
ability to make certain distributions. Upon the occurrence and during the
continuation of an event of default under the SNB Loan Agreement, SNB may, among
other things, declare the loans and all other obligations under the SNB Loan
Agreement immediately due and payable and increase the interest rate at which
loans and obligations under the SNB Loan Agreement bear interest. The SNB Credit
Facility is secured by a first-priority security interest in substantially all
of the assets of the Company and the SNB Borrowers and a pledge of all shares of
the SNB Borrowers.
On March 29, 2019, in connection with the Company's entry into the SNB Loan
Agreement, Jeffery E. Eberwein, the Executive Chairman of the Company's board of
directors, entered into Limited Guaranty Agreement (the "SNB Eberwein Guaranty")
with SNB pursuant to which he guaranteed the prompt performance of all the
Borrowers' obligations under the SNB Loan Agreement. The SNB Eberwein Guaranty
is limited in the aggregate to the amount of (a) $1.5 million, plus (b)
reasonable costs and expenses of SNB incurred in connection with the SNB
Eberwein Guaranty. Mr. Eberwein's obligations under the SNB Eberwein Guaranty
terminate upon the Company and Borrowers achieving certain milestones set forth
therein.
On February 1, 2021, in connection with the closing of the Company's sale of MD
Office Solutions, the Company entered into a First Amendment to the SNB Loan
Agreement pursuant to which, among other things, Sterling consented to the sale
of MD Office Solutions and the Company's name change from Digirad Corporation to
Star Equity Holdings, Inc.
On March 31, 2021, in connection with completing the sale of DMS Health, the
Company, certain subsidiaries of the Company, and Sterling entered into a Second
Amendment to the SNB Loan Agreement pursuant to which, among other things,
Sterling consented to the sale of DMS Health and its subsidiaries, removed DMS
Health and its subsidiaries as borrowers under the SNB Loan Agreement, and
required the principle to be paid down to $7.0 million.
At March 31, 2021, the Company was in compliance with the covenants under the
SNB Loan Agreement.
Construction Loan Agreements
As of March 31, 2021, the Construction division had outstanding revolving lines
of credit of approximately $5.4 million. This debt includes: (i) $2.7 million
principal outstanding on KBS's $4.0 million revolving credit facility under a
Loan and Security Agreement, dated February 23, 2016, (as amended, the "KBS Loan
Agreement"), with Gerber and (ii) $2.0 million principal outstanding on EBGL's
$3.0 million revolving credit facility under a Revolving Credit Loan Agreement,
and $0.7 million with Premier, dated June 30, 2017 (as amended, the "Premier
Loan Agreement"). The Construction division was at the maximum borrowing
capacity under both revolving lines of credit, based on the inventory and
accounts receivable on March 31, 2021, which fluctuates weekly.
KBS Loan Agreement
On February 23, 2016, ATRM, KBS and Main Modular Haulers, Inc. (a former
subsidiary of ATRM) entered into a Loan and Security Agreement, (as amended, the
"KBS Loan Agreement"), with Gerber. The KBS Loan Agreement provides KBS with a
revolving line of credit with borrowing availability of up to $4.0 million.
Availability under the line of credit is based on a formula tied to KBS's
eligible accounts receivable, inventory and other collateral. The KBS Loan
Agreement, which was scheduled to expire on February 22, 2018, has been
automatically extended for successive one (1) year periods in accordance with
its terms and is now scheduled to expire on February 22, 2022. The KBS Loan
Agreement will be automatically extended for another one (1) year period unless
a party thereto provides prior written notice of termination. As of March 31,
2021 neither party has provided notice of termination. Upon the final expiration
of the term of the KBS Loan Agreement, the outstanding principal balance is
payable in full. Borrowings bear interest at the prime rate plus 2.75%, equating
to 6.00% at March 31, 2021, with interest payable monthly. The KBS Loan
Agreement also provides for certain fees payable to Gerber during its term,
including a 1.5% annual facilities fee and a 0.10% monthly collateral monitoring
fee. KBS's obligations under the KBS Loan Agreement are secured by all of its
assets and are guaranteed by ATRM. Unsecured promissory notes issued by KBS and
ATRM are subordinate to KBS's obligations under the KBS Loan Agreement. The KBS
Loan Agreement contains representations, warranties, affirmative and negative
covenants, defined events of default and other provisions customary for
financings of this type. Financial covenants require that KBS maintain a maximum
leverage ratio (as defined in the KBS Loan Agreement) and KBS not incur a net
annual post-tax loss in any fiscal year during the term of the KBS Loan
Agreement. The borrowings under the KBS Loan Agreement were classified as
short-term obligations under GAAP as the agreement contained a subjective
acceleration clause and required a lockbox arrangement whereby certain receipts
are swept daily to reduce borrowings outstanding. At March 31, 2021,
approximately $2.7 million was outstanding under the KBS Loan Agreement.
During the three months ended, March 31, 2021, the parties to the KBS Loan
Agreement have amended the KBS Loan Agreement to provide for increased
availability under the KBS Loan Agreement to KBS under certain circumstances,
including for new equipment additions, and certain other changes, as well as a
waiver of certain covenants.
                                       48
--------------------------------------------------------------------------------


As of December 31, 2020 and 2019, KBS was not in compliance with the financial
covenants requiring no net annual post-tax loss for KBS or the minimum leverage
ratio covenant as of 2020. The occurrence of any event of default under the KBS
Loan Agreement may result in KBS's obligations under the KBS Loan Agreement
becoming immediately due and payable. In April 2019, June 2019, February 2020
and February 2021, we obtained a waiver from Gerber for these events.
On September 10, 2019, the parties to the KBS Loan Agreement entered into the
twelfth amendment to the KBS Loan Agreement (the "Twelfth KBS Amendment"),
pursuant to which the Company agreed to guarantee amounts borrowed by certain
ATRM's subsidiaries from Gerber.
On January 31, 2020, the Company, ATRM, KBS and Gerber entered into a thirteenth
amendment to the KBS Loan Agreement (the "Thirteenth KBS Amendment") to amend
the terms of the KBS Loan Agreement, in order to, among other things (a) amend
the definitions of "Ancillary Credit Parties," "Guarantor," "Obligations," and
"Subordinated Lender" to address the obligations of the Star Borrowers, the EBGL
Borrowers, the Star Credit Parties, and the EBGL Credit Parties under the Star
Loan Agreement, EBGL Loan Agreement and the Subordination Agreements (each as
defined below) to which they are a party and (b) add a new cross default
provision.
On March 5, 2020, in connection with the First EBGL Amendment, Gerber, KBS, ATRM
and the Company entered into a fourteenth amendment to the KBS Loan Agreement in
order to, among other things consent to the First EBGL Amendment and remove cash
and cash collateral from the borrowing base.
On April 1, 2020, Gerber and KBS entered into a fifteenth amendment to the KBS
Loan Agreement pursuant to which the "Minimum Average Monthly Loan Amount" was
decreased to twenty-five percent (25%) of the Maximum Revolving Amount.
On January 5, 2021, Gerber and KBS entered into a sixteenth amendment to the KBS
Loan Agreement in order to, among other things, amend certain definitions under
the KBS Loan Agreement and to increase the inventory assets against which funds
can be borrowed.
On February 26, 2021 Gerber and KBS entered into a seventeenth amendment to the
KBS Loan Agreement in order to provide the waiver to the 2020 covenant breach
and amended the financial covenants. The financial covenants under the KBS Loan
Agreement, as amended, provide that (i) KBS shall make no distribution,
transfer, payment, advance, or contribution of cash or property which would
constitute a restricted payment; (ii) KBS shall report annual post-tax net
income at least equal to (a) $385 thousand for the trailing 6-month period
ending June 30, 2021 and (b) $500 thousand for the trailing fiscal year end
December 31, 2021; and (iii) a minimum EBITDA at June 30, 2021 of more than
$880 thousand or at December 31, 2021 of more than $1.5 million.
EBGL Premier Note
On June 30, 2017, EdgeBuilder and Glenbrook (together, EBGL) entered into a
Revolving Credit Loan Agreement (as amended, the "Premier Loan Agreement") with
Premier providing EBGL with a working capital line of credit of up to
$3.0 million. The Premier Loan Agreement replaced the prior revolving credit
facility.
Availability under the Premier Loan Agreement is based on a formula tied to
EBGL's eligible accounts receivable, inventory and equipment, and borrowings
bear interest at the prime rate plus 1.50%, with interest payable monthly and
the outstanding principal balance payable upon expiration of the term of the
Premier Loan Agreement. The Premier Loan Agreement also provides for certain
fees payable to Premier during its term. The initial term of the Premier Loan
Agreement was scheduled to expire on June 30, 2018, but was extended multiple
times by Premier until January 31, 2023. EBGL's obligations under the Premier
Loan Agreement are secured by all of their inventory, equipment, accounts and
other intangibles, fixtures and all proceeds of the foregoing.
On January 31, 2020, Glenbrook and EdgeBuilder entered into an Extension and
Modification Agreement (the "Modification Agreement") with Premier that modified
the terms of the Revolving Credit Promissory Note made by Glenbrook and
EdgeBuilder. The Modification Agreement reduced the outstanding borrowings to
$1.0 million, extended the final maturity date to January 31, 2023, and set the
interest rate to at 5.75% per annum. Mr. Eberwein executed a guaranty in favor
of Premier, which has been extended through January 1, 2023, under which ATRM
and Mr. Eberwein have absolutely and unconditionally guaranteed all of EBGL's
obligations under the Premier Loan Agreement. As of March 31, 2021,
approximately $0.7 million was outstanding under the Premier Loan Agreement.
                                       49
--------------------------------------------------------------------------------


Gerber Star and EBGL Loans
On January 31, 2020, SRE, 947 Waterford Road, LLC ("947 Waterford"), 300 Park
Street, LLC ("300 Park"), and 56 Mechanic Falls Road, LLC ("56 Mechanic" and
together with SRE, 947 Waterford, and 300 Park, (the "Star Borrowers"), each an
Investments Subsidiary, and the Company, ATRM, KBS, EdgeBuilder, and Glenbrook
(collectively, the "Star Credit Parties"), entered into a Loan and Security
Agreement (as amended, the "Star Loan Agreement") with Gerber providing the Star
Borrowers with a credit facility with borrowing availability of up to
$2.5 million ($2.0 million and $0.5 million to KBS and EBGL, respectively) (the
"Star Loan"). The advance of $2.0 million to KBS is to be repaid in monthly
installments of sixty (60) consecutive equal payments. The advance of
$0.5 million to EBGL, which has been temporarily increased by $0.3 million due
to be repaid on April 30, 2020, is to be repaid in monthly installments of
twelve (12) consecutive equal payments. On February 20, 2020, the Star Borrowers
entered into a first amendment to the Star Loan Agreement (the "First Star
Amendment") in order to (i) temporarily advance $0.3 million to EBGL, which
amount is to be repaid to Gerber on or before April 30, 2020; (ii) clarify that
Gerber can make multiple advances under the Star Loan Agreement, and (iii) to
correct the maturity date of the Star Loan. On April 30, 2020, the Star
Borrowers entered into a second amendment to the Star Loan Agreement (the
"Second Star Amendment") to change terms of repayment for the advance of
$0.3 million to EBGL to provide for repayment in three consecutive equal monthly
installments, commencing on May 30, 2020, with a final installment on or before
July 31, 2020. As of March 31, 2021, EBGL repaid approximately $0.5 million and
$1.3 million was outstanding under the Star Loan Agreement.
On January 31, 2020, EdgeBuilder and Glenbrook (the "EBGL Borrowers"), each a
Construction Subsidiary, and the Company, Star, 947 Waterford, 300 Park, 56
Mechanic, ATRM, and KBS (collectively, the "EBGL Credit Parties"), entered into
a Loan and Security Agreement (the "EBGL Loan Agreement") with Gerber providing
the EBGL Borrowers with a credit facility with borrowing availability of up to
$3.0 million (the "EBGL Loan"). On March 5, 2020, the EBGL Borrowers entered
into a first amendment to the EBGL Loan Agreement (the "First EBGL Amendment")
with Gerber that amended the EBGL Loan Agreement and the KBS Loan Agreement to
include a pledge $0.3 million of cash collateral by LSVI under the EBGL Loan
Agreement which, prior to the First EBGL Amendment, was pledged by LSVI in
connection with the KBS Loan Agreement. On July 1, 2020, the EBGL Borrowers
entered into a second amendment to the EBGL Loan Agreement to terminate the
pledge of $0.3 million in cash collateral. On February 26, 2021, the EBGL
Borrowers entered into a third amendment to the EBGL Loan Agreement (the "Third
EBGL Amendment") pursuant to which the Company and Gerber agreed to, among other
things, eliminate the minimum leverage ratio covenant, lower the minimum EBITDA,
and require the borrowers to not incur a net operating loss on bi-annual basis.
The Third EBGL Amendment also discharged the EBGL Eberwein Guaranty described
below. As of March 31, 2021, approximately $2.0 million was outstanding under
the EBGL Loan Agreement.
Availability under the Star Loan Agreement is based on a formula tied to the
value of real estate owned by the Star Borrowers, and borrowings bear interest
at the prime rate plus 3.5% per annum. Availability under the EBGL Loan
Agreement is based on a formula tied to the EBGL Borrowers' eligible accounts
receivable and inventory, and borrowings bear interest at the prime rate plus
2.75% per annum. The Loan Agreements also provide for certain fees payable to
Gerber during their respective terms. The Star Loan matures on the earlier of
(a) January 1, 2025 or (b) the termination, the maturity or repayment of the
EBGL Loan. The EBGL Loan matures on the earlier of (a) January 1, 2022, unless
extended, or (b) the termination, the maturity or repayment of the Star Loan.
The maturity of the EBGL Loan is automatically extended for successive periods
of one (1) year each unless terminated by Gerber or the EBGL Borrowers. The
borrowings under the EBGL Loan Agreement were classified as short-term
obligations under GAAP as the agreement contained a subjective acceleration
clause and required a lockbox arrangement whereby all receipts are swept daily
to reduce borrowings outstanding.
                                       50
--------------------------------------------------------------------------------


The obligations of the EBGL Borrowers under the EBGL Loan Agreement are
guaranteed by the EBGL Credit Parties and are secured by substantially all the
assets of the EBGL Borrowers and the EBGL Credit Parties. The obligations of the
Star Borrowers under the Star Loan Agreement are guaranteed by the Star Credit
Parties and are secured by substantially all the assets of the Star Borrowers
and the Star Credit Parties. Contemporaneously with the execution and delivery
of the Star Loan Agreement, Jeffrey E. Eberwein, the Executive Chairman of the
Company's board of directors, executed and delivered a Guaranty (the "Gerber
Eberwein Guaranty") to Gerber pursuant to which he guaranteed the performance of
all the Star Borrowers' obligations to Gerber under the Star Loan Agreement,
including the full payment of all indebtedness owing by the Star Borrowers to
Gerber under or in connection with the Star Loan Agreement and related financing
documents. Mr. Eberwein's obligations under the Gerber Eberwein Guaranty are
limited in the aggregate to the amount of (a) $2.5 million, plus (b) costs of
Gerber incidental to the enforcement of the Gerber Eberwein Guaranty or any
guaranteed obligations. On March 5, 2020, contemporaneously with the execution
and delivery of the First EBGL Amendment, Mr. Eberwein, the Executive Chairman
of the Company's board of directors, executed and delivered a Guaranty (the
"EBGL Eberwein Guaranty") to Gerber pursuant to which he guaranteed the
performance of all the EBGL Borrowers' obligations to Gerber under the EBGL Loan
Agreement, including the full payment of all indebtedness owing by the EBGL
Borrowers to Gerber under or in connection with the EBGL Loan Agreement and
related financing documents. Mr. Eberwein's obligations under the EBGL Eberwein
Guaranty are limited in the aggregate to the amount of (a) $0.5 million, plus
(b) costs of Gerber incidental to the enforcement of the EBGL Eberwein Guaranty
or any guaranteed obligations.
On February 26, 2021, the Star Borrowers entered into a third amendment to the
Star Loan Agreement (the "Third Star Amendment") with Gerber that, among other
things, amended the contract rate to prime rate plus 3% and discharged the
$2.5 million Gerber Eberwein Guaranty.
The Star Loan Agreement and EBGL Loan Agreement contains representations,
warranties, affirmative and negative covenants, events of default and other
provisions customary for financings of this type. The financial covenants under
the EBGL Loan Agreement applicable to the EBGL Borrowers include maintenance of
a minimum tangible net worth, a minimum debt service coverage ratio and minimum
net income. The Financial covenants under the Star Loan Agreement applicable to
the Star Borrowers include a minimum debt service coverage ratio. The occurrence
of any event of default under the Loan Agreements may result in the obligations
of the Borrowers becoming immediately due and payable. As of December 31, 2020,
EBGL was not in compliance with the financial covenants under the Star Loan
Agreement and EBGL Loan Agreement as of 2020. The occurrence of any event of
default under the EBGL Loan Agreement may result in EBGL's obligations under the
EBGL Loan Agreement becoming immediately due and payable. In February 2021, we
obtained a waiver from Gerber for these events and, as part of the Third EBGL
Amendment (described above), the Company and Gerber agreed to, among other
things, eliminate the minimum leverage ratio covenant, lower the minimum EBITDA,
and require the borrowers to not incur a net operating loss on bi-annual basis,
as well as discharge the EBGL Eberwein Guaranty.
As a condition to the extension of credit to the Star Borrowers and EBGL
Borrowers under the Star Loan Agreement and EBGL Loan Agreement, the holders of
certain existing unsecured promissory notes made by ATRM and certain of its
subsidiaries entered into subordination agreements (the "Subordination
Agreements") with Gerber pursuant to which such noteholders (including the
Company and certain of its subsidiaries) agreed to subordinate the obligations
of ATRM and its subsidiaries to such noteholders to the obligations of the Star
Borrowers and EBGL Borrowers to Gerber under the loan agreements.
Paycheck Protection Program
From April 2020 through May 2020, the Company and its subsidiaries received $6.7
million, of loans under the Paycheck Protection Program ("PPP"). Total PPP loans
received the Construction division and Healthcare division were $5.5 million and
$1.2 million, respectively.
The PPP was established under the Coronavirus Aid, Relief, and Economic Security
Act (the "CARES Act") and is administered by the U.S. Small Business
Administration ("SBA"). PPP loans for the Construction and Healthcare division
were made through Bremer Bank and Sterling as lenders, respectively.
The PPP loans have two-year terms and bear interest at a rate of 1.00% per
annum. Monthly principal and interest payments under the PPP loans are deferred
for ten months, after the end of covered periods. The PPP loans may be prepaid
at any time prior to maturity with no prepayment penalties.
The promissory notes issued in connection with the PPP loans (the "PPP Notes")
contain customary events of default relating to, among other things, payment
defaults, making materially false and misleading representations to the SBA or
lender, or breaching the terms of the applicable PPP loan documents. Upon an
event of default under a PPP Note, the lender thereunder may, among other
things, require immediate payment of all amounts owing under the applicable PPP
Note, collect all amounts owing from the applicable borrower, or file suit and
obtain judgment.
                                       51

--------------------------------------------------------------------------------




Under the terms of the CARES Act, recipients of loans under the PPP can apply
for and be granted forgiveness for all or a portion of the loan granted under
the PPP. Such forgiveness will be determined, subject to limitations, based on
the use of loan proceeds for payment of payroll costs and certain other eligible
costs. However, no assurance is provided that forgiveness for any portion of the
PPP loans will be obtained and even if forgiveness is granted the PPP loans may
remain subject to review and audit due to all affiliated PPP Notes equaling more
than $2 million.
In order to apply for the PPP loans, we certified that the economic uncertainty
at the time of application, made the PPP loans request necessary to support
ongoing operations of the Company. This certification was made taking into
account our then current business activity and our ability to access other
sources of liquidity sufficient to support ongoing operations in a manner that
would not be significantly detrimental to the business.
The Company is continuing to evaluate the criteria and new guidance put out by
the SBA regarding loan forgiveness criteria and procedures to seek loan
forgiveness. During October 2020 and January 2021, the Company applied for
forgiveness on all PPP loans. Our PPP loan forgiveness is sought under the
belief all entities requesting loan forgiveness have met the stated criteria and
guidelines provided by the SBA and terms of the CARES Act; however, no assurance
can be provided that forgiveness for any portion of the PPP loans will be
obtained.
During Q4 2020, $2.5 million of the Healthcare division PPP Notes were forgiven.
As of March 31, 2021, the Company has $3.0 million in PPP loans outstanding for
the Healthcare division. During Q1, 2021, all amounts under the Construction
division PPP Notes were forgiven.
Off-Balance Sheet Arrangements
On September 10, 2019, the parties to the KBS Loan Agreement entered into the
Twelfth KBS Amendment pursuant to which the Company agreed to guarantee amounts
borrowed by certain of ATRM's subsidiaries from Gerber. The Twelfth KBS
Amendment requires the Company to serve as an additional guarantor with the
existing guarantor, ATRM, with respect to the payment, performance and discharge
of each and every obligation of payment and performance by the borrowing
subsidiaries with respect to the loans made by Gerber to them. On January 31,
2020, the Company, ATRM, KBS and Gerber entered into the Thirteenth KBS
Amendment, in order to, among other things (a) amend the definitions of
"Ancillary Credit Parties," "Guarantor," "Obligations," and "Subordinated
Lender" to address the obligations of the Star Borrowers, the EBGL Borrowers,
the Star Credit Parties, and the EBGL Credit Parties under the Star Loan
Agreement, the EBGL Loan Agreement and the Subordination Agreements to which
they are a party and (b) add a new cross default provision. On April 1, 2020,
Gerber and KBS entered into a Fifteenth KBS Amendment pursuant to which the
"Minimum Average Monthly Loan Amount" under the KBS Loan Agreement was decreased
to twenty-five percent (25%) of the Maximum Revolving Amount (as defined in the
KBS Loan Agreement). See Note 8, Debt, within the notes to our unaudited
consolidated financial statements for further detail.

On June 5, 2020, the Company entered into a Guaranty Agreement (the "Tocci
Guaranty") with Tocci Building Corporation ("Tocci") pursuant to which the
Company irrevocably guaranteed all the obligations of KBS under a certain
Subcontract Agreement by and between Tocci and KBS in the event of a material
breach by KBS under the Subcontract. The Company's liability under the Tocci
Guaranty is limited to $2.0 million.

© Edgar Online, source Glimpses